Ethical Policy of International Center for Intelligent Research
ethical policy of International Center for Intelligent Research is based on the Committee on Publication Ethics (COPE) guidelines and complies with International Committee of Medical Journal Editors (ICMJE) codes of conduct. statements confirm that confidentiality and fairness should be considered in all the ICIR procedures and interactions. Readers, authors, reviewers and editors should follow these ethical policies once working with International Center for Intelligent Research.
Editorial-Open Access Policy
International Center for Intelligent Research provides publishing services for peer-reviewed, online and print-plus-online journals in medicine. ICIR operates the Open access model of publishing services, providing unrestricted online access to peer-reviewed scholarly research. Abstracts and full texts (PDF format) of all articles published by ICIR are freely accessible to everyone immediately upon publication. International Center for Intelligent Research provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. The Journal is an open access journal; individuals can freely access, read, save, copy, scan, link the entire text, index, transfer the published content into software’s and use the published content for all legal purposes. The contents of all journals are open to access in line with the policy of Budapest Open Access Initiative for developing, supporting and extending the science. If the purpose is scientific citations, other than commercial purposes, the contents of all journals can be used by the license of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). For the use of commercial purposes, individuals need to take written permission from the journal. The journal has article processing charges (APCs) and/or submission charges. The contents of all ICIR Journals are licensed under Creative Commons Attribution-NonCommercial 4.0 International License.
Peer Review Process
When the submitted articles arrived to the ICIR journals, one of the Editors read each manuscript. Editors have to decided first decision very quickly. We aim to reach a first decision on all manuscripts within one or two weeks of submission. During the first decision, journal editors mainly check: does the manuscript fit the journals scope and aim and minimum acceptable quality? Is the manuscript compliant with the journals instructions for author? Editor decides whether or not to send it for full peer review. If a paper is rejected without external review, authors are notified electronically on decision time by email. We retain copies of rejected manuscripts for three months, after which we delete them from our system. Only after clearing the initial screening is the manuscript sent to peer reviewers. Minimum of two peer reviewers are selected for peer-review process. Names of reviewers and authors are not revealed to each other. We ask authors to declare potential conflicts of interest any of the reviewers. The final decision concerning the manuscript is made during the regular Editorial meeting. All the evaluation reports from the reviewers are reviewed and final decision is reached on the base of originality, quality, importance, scientific merit and ethical issues of the article. All authors are asked to submit any conflict of interest and complete and sign the Copyright Release Form. We send the reviewers’ comments to authors whether or not we accept the article. Linguistic corrections are made by the native English language editors when we think that it is acceptable.
Policy statement – Conflict of Interest
Authors publishing articles in journals published by International Center for Intelligent Research must declare all financial disclosures and conflicts of interest in the cover letter and on the title page of manuscripts submitted for publication. All submitted manuscripts must include a ‘competing interests’ section at the end of the manuscript listing all competing interests (financial and non-financial). Where authors have no competing interests, the statement should read “The authors have declared that no competing interests exist.” Editors may ask for further information relating to competing interests. Editors and reviewers are also required to declare any competing interests and will be excluded from the peer review process if a competing interest exists.
Policy statement – Human and Animal Rights
All studies submitted to International Center for Intelligent Research for publication must be in compliance with institutional and international regulations for human and animal studies such as the Helsinki declaration. Human studies require ethics committee approval and informed consent which must be documented in your manuscript. Animal studies require ethics committee approval and must conform to international guidelines for animal research. Compliance with these requirements must be documented in your manuscript. Experimental research on vertebrates or any regulated invertebrates must comply with institutional, national, or international guidelines, and where available should have been approved by an appropriate ethics committee. A statement detailing compliance with guidelines and/or ethical approval must be included in the manuscript. For studies involving client-owned animals, authors must document informed client consent and adherence to a high standard (best practice) of veterinary care. If a study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee that granted the exemption). Further information and documentation to support this should be made available to Editors on request. Manuscripts may be rejected if the Editor considers that the research has not been carried out within an appropriate ethical framework. In rare cases, Editors may contact the ethics committee for further information.
Policy statement – Informed Consent
All human studies submitted for publication in International Center for Intelligent Research require informed consent and ethics committee approval. If waiver of consent was granted by the ethics committee in the case of retrospective studies not impacting on patient confidentiality or patient rights, this must be clearly stated in the cover letter and manuscript. For all research involving human subjects, informed consent to participate in the study should be obtained from participants (or their parent or guardian in the case of children under 16) and a statement to this effect should appear in the manuscript. For all manuscripts that include details, images, or videos relating to individual participants, written informed consent for the publication of these must be obtained from the participants (or their parent or legal guardian in the case of children under 16) and a statement to this effect should appear in the manuscript. If the participant has died, then consent for publication must be sought from the next of kin of the participant. This documentation must be made available to Editors on request, and will be treated confidentially. In cases where images are entirely unidentifiable and there are no details on individuals reported within the manuscript, consent for publication of images may not be required. The final decision on whether consent to publish is required lies with the Editor.
International Center for Intelligent Research verifies the originality of submitted manuscripts through plagiarism software. ICIR journals routinely verify the originality of content submitted using Similarity Check (powered by iThenticate) to check submissions against previous publications. If a large amount of text is found to be plagiarized, then the manuscript is subject to rejection. But in case of minor plagiarism where author makes unattributed usage of few phrases of standard methods description or parts of introduction from a previously published paper, the editor contacts author and raises concerns regarding plagiarized material. The decision regarding rejection or consideration of article would be made after receiving the article with proper attributions and corrections. If plagiarism is found after publication, the journal conducts required investigation and contacts author for any minor corrections. If major plagiarism is found in the published article, the journal retracts the paper and informs the same to all authors and/or author’s institution and/or funding agencies. The Plagiarism is a serious ethical offense and is subject to sanctions like penalties, suspension, and even expulsion.
Data Fabrication and Data Falsification
Data fabrication is the practice of inventing data or results, making up the data and recording and/or reporting them in the research record. Data falsification is the manipulation of research data with the intention of giving a false impression. These include modifying images, omitting conflicting data or inconvenient results, changing, adding or removing data points, selective reporting of research findings etc.
International Center for Intelligent Research is strictly against to data fabrication and data manipulation. They represent serious issues in scientific ethics, diluting and undermining the integrity of scientific literature. Both these schemes challenge the credibility of everyone and everything involved in a research effort. They lead others to erroneous conclusions that may have adverse consequences for patients in clinical research and clinical practice. It could waste other researcher’s time, effort, resources and energies attempting to replicate or build on the data presented in a falsified paper. With regard to images, International Center for Intelligent Research accepts the improvement of images for better readability such as adjusting the contrast and/or brightness or color balance but only when the usage of the images are properly acknowledged to the author of the original image. The technical manipulation of the image such as removing or adding new elements into the image, is considered as data fabrication and the journal does not accept such image manipulations. If data fabrication or data falsification is found, the editors may return the paper without review, announces the issue publicly in an editorial, bans the author from submitting articles in this journal, and/or contact the authors’ employers/academic institution.
International Center for Intelligent Research keeps all details of a submitted manuscript confidential and do not comment or publicize about manuscripts while they are under consideration or when they are rejected. The editors and reviewers themselves are not allowed to discuss or reveal the data of the manuscripts and any associated supplementary material before its publication. They are not allowed to use knowledge that they have gained from an unpublished article to further their own interests. However, they are free to discuss the data once the article is published. The comments and feedback of the reviewers will not be published and the identity of the reviewers will remain anonymous. Reviewers are not permitted to share the manuscript with lab members as a whole or with colleagues outside of the lab for reviewing purposes. If the reviewer wishes to review an article along with a junior member of their laboratory, the reviewer must get approval from the editor. The junior member must be named as a co-reviewer and the same rules of confidentiality and publishing ethics will be applied to the co-reviewer.
Committee on Publication Ethics (COPE)
International Center for Intelligent Research adheres the policies of the Committee on Publication Ethics (COPE), which is a charity registered in the UK. It is concerned with the integrity of peer-reviewed publications in science, particularly biomedicine.
International Committee of Medical Journal Editors (ICMJE)
International Center for Intelligent Research endorses the policies of the International Committee of Medical Journal Editors (ICMJE), including those that cover overlapping publications.
International Center for Intelligent Research, LLC, Tbilisi, Georgia